Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

NCT00126724 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid
Arthritis, Psoriatic
Ankylosing Spondylitis

Interventions

GENETIC: tgAAC94 gene therapy vector
GENETIC: tgAAC94 gene therapy vector
GENETIC: tgAAC94 placebo
GENETIC: tgAAC94 gene therapy vector
GENETIC: tgAAC94 gene therapy vector
GENETIC: tgAAC94 gene therapy vector
GENETIC: tgAAC94 gene therapy vector

Sponsor

Targeted Genetics Corporation